Position in ALKS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$221,809
New position
Shares Held
4,233
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#299
of 421 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SAGE RHINO CAPITAL LLC holds $1,801,591 across 6 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
9,524 | $684,394 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
8,885 | $301,023 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
476 | $257,911 | |
| 4 | ALKS |
Alkermes plc.
This page
|
4,233 | $221,809 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
11,939 | $191,382 | |
| 6 | HLN |
Haleon plc
|
15,549 | $145,072 |
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $221,809 | 4,233 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||